Synonyms:METAXALONE, 1665-48-1, Skelaxin, Zorane, Methaxalonum, Metaxalon, 5-((3,5-Dimethylphenoxy)methyl)oxazolidin-2-one, Methoxolone, Metazalone, Metazolone, Metaxolone, AHR-438, Metaxalonum [Latin], Metassalone [DCIT], 5-[(3,5-Dimethylphenoxy)methyl]-1,3-oxazolidin-2-one, 2-Oxazolidinone, 5-[(3,5-dimethylphenoxy)methyl]-, AHR 438, Metaxalonum [INN-Latin], Metaxalona [INN-Spanish], NSC 170959, 5-(3,5-Xyloloxymethyl)oxazolidin-2-one, CL 39,148, 5-[(3,5-Xylyloxy)methyl]-2-oxazolidinone, Flexura, 2-Oxazolidinone, 5-((3,5-xylyloxy)methyl)-, 5-((3,5-Dimethylphenoxy)methyl)-2-oxazolidinone, 5-((3,5-Xylyloxy)methyl)-2-oxazolidinone, MFCD00867700, NSC170959, 5-[(3,5-dimethylphenoxy)methyl]oxazolidin-2-one, NSC-170959, 2-Oxazolidinone, 5-((3,5-dimethylphenoxy)methyl)-, 5-(3,5-dimethylphenoxymethyl)-1,3-oxazolidin-2-one, MLS003106749, 1NMA9J598Y, CHEBI:6797, DTXSID3023269, 5-[(3,5-Dimethylphenoxy)methyl]-2-oxazolidinone, NCGC00095116-01, 2-Oxazolidinone, 5-[(3,5-xylyloxy)methyl]-, DTXCID103269, Metaxalona [Spanish], Metassalone, Metaxalona, Metaxalonum, CAS-1665-48-1, Metaxalone [USAN:INN:BAN], HSDB 3236, SR-05000001978, EINECS 216-777-6, 5-((3,5-Dimethylphenoxy)methyl)-1,3-oxazolidin-2-one, BRN 0884592, UNII-1NMA9J598Y, .meta.Xalone, .meta.Zalone, .meta.Zolone, .meta.Xalon, Skelaxin (TN), Spectrum_001741, METAXALONE [MI], SpecPlus_000656, Metaxalone (USP/INN), METAXALONE [INN], Spectrum2_000548, Spectrum3_001666, Spectrum4_000612, Spectrum5_001685, METAXALONE [HSDB], METAXALONE [USAN], METAXALONE [VANDF], 5-(3,5-dimethylphenoxymethyl)-2-oxazolidinone, METAXALONE [MART.], METAXALONE [USP-RS], METAXALONE [WHO-DD], Oprea1_438855, SCHEMBL34908, BSPBio_003451, KBioGR_001164, KBioSS_002221, DivK1c_006752, SPECTRUM1504229, SPBio_000595, AHR438, GTPL7609, CHEMBL1079604, METAXALONE [ORANGE BOOK], Metaxalone, >=98% (HPLC), KBio1_001696, KBio2_002221, KBio2_004789, KBio2_007357, KBio3_002671, HMS1922H07, HMS2093C22, METAXALONE [USP MONOGRAPH], Pharmakon1600-01504229, BCP28377, HY-B0678, Tox21_111428, WLN: T5MVOTJ D1OR C1 E1, 2-Oxazolidinone,5-xylyloxy)methyl]-, CCG-39592, NSC758703, s3730, STL450994, STL451511, AKOS009035315, Tox21_111428_1, DB00660, FS-3218, NSC-758703, NCGC00095116-02, NCGC00095116-03, NCGC00095116-05, SMR001821638, SY052772, SBI-0052859.P002, 2-Oxazolidinone,5-dimethylphenoxy)methyl]-, DB-043656, AM20060525, FT-0603568, M2578, 5-(3,5-dimethylphenoxy)methyl-2-oxazolidinone, C07934, D00773, EN300-119839, AB00053284_04, A810747, J-010295, Q6823309, SR-05000001978-1, SR-05000001978-3, BRD-A94709349-001-02-6, BRD-A94709349-001-03-4, Z106952910, 5-[(3,5-Dimethylphenoxy)methyl]-1,3-oxazolidin-2-one #, 5-{[(3,5-dimethylphenyl)oxy]methyl}-1,3-oxazolidin-2-one, 5-[(3,5-dimethylphenoxy)methyl]-4,5-dihydro-1,3-oxazol-2-ol, Metaxalone, United States Pharmacopeia (USP) Reference Standard
Pubchem:PUBCHEM:15459
Id:e96fc45d-18ca-5d2f-a4b4-b9fa0d229b75
Description:nan
